1 Day

No-Intervention Placeholder

STUDY TITLE No-Intervention Placeholder
Submitted under umbrella

Umbrella Protocol for Efforia Personalized Agentic Hypothesis Discovery & Experiential Proof Trials

Date submitted

—

End date

There is no pre-specified end date and sub-studies remain open long-term.

Language

English

Efforia AI IRB approval recommendation

—

Recruitment page preview

Preview

Informed consent

Review

Study author

Principal investigator

Matthew Amsden

Sub-Investigator for Adverse Events

Dr. Viral Patel

Description

This draft uses a no-intervention placeholder while the sponsor decides whether a more suitable protocol direction should be developed. Participants receive a brief orientation explaining that no treatment activity is currently assigned. The purpose is to avoid introducing extra routines or variables before the intervention concept is clarified.

Participant engagement length

1 Day

Sponsor

This study is made possible by your payment to cover all supplies and expenses required to participate.

Cost to participant

$0

Included products & services

—

Outcome measures

—

Methodology

Single Arm longitudinal where participants act as their own control

Basic or advanced dissemination plan

Basic

Deviation from recruitment approach

No

Deviation from statistical approach

No

Will study include “more about you questions”

No

ClinicalTrials.gov

Yes

Commitment to list findings on ClinicalTrials.gov

Yes

This document is prepared with the assistance of AI, but is reviewed by a human.

Rational & Study Design

Reason I Created This Protocol:

Health optimization is crowded with bold claims, viral routines, and “must-do” rituals—but sometimes the smartest move is to pause before adding more noise. This no-intervention placeholder protects the study from premature variables while the sponsor clarifies the right direction. Clean science needs a clean runway.

My Objective For You:

My objective is to give you a clear, low-burden orientation while intentionally avoiding new treatments, products, or routines. For now, your job is simple: understand the protocol status, avoid unnecessary behavior changes, and help preserve a clean baseline until a defined intervention is ready.

Aims & Objectives:

This protocol aims to prevent premature intervention exposure while maintaining participant engagement, clarity, and study readiness. You will receive personalized study-relevant information based on what is collected, and if a future intervention is added, those results may help you judge whether the products or services are worth your time, money, and effort.

Significance & Impact:

This study matters because doing nothing—on purpose—can be scientifically useful when the alternative is introducing an untested routine before the research question is ready. Expected outcomes include clearer protocol development, reduced confounding, and better participant alignment; limitations include the absence of active treatment, assigned products, or direct health-effect testing at this stage.

The Intervention

Included Products & Services

Study Design & Methodology

Inappropriate Participants & Inclusion/Exclusion

Study Design & Experience

Statistical Analysis Plan

Limitations & Justification

Human Subjects Ethics

Suitability Under Minimal Risk Umbrella Protocol

Suitability for Pay to Participate Model

Human Subjects Protection Questionnaire